Plasma fibrinogen concentration is increased following depletion of vitamin K-dependent clotting factors by the indirect anticoagulant difenacoum in Norway rats (Rattus norvegicus)

Comparative Haematology International

Volumn 9, Issue 2, 1999, Pages 76-82

  Kerins, G M ^a  

^a CENTRE FOR ENVIRONMENT   (United Kingdom)

Author keywords

Anticoagulant; Fibrinogen; Rats; Resistance; Rodents

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; DIFENACOUM; FIBRINOGEN; PROTHROMBIN; VITAMIN K GROUP;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESISTANCE; FEEDBACK SYSTEM; FEMALE; FIBRINOGEN BLOOD LEVEL; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTHROMBIN TIME; RAT;

EID: 0032720134     PISSN: 09387714     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02585540     Document Type: Article

References (18)

1. Drummond DC, Wilson EJ (1968) Laboratory investigations of resistance to warfarin of Rattus norvegicus Berk, in Montgomeryshire and Shropshire. Ann Appl Biol 61:303-312
2. Gill JE, Kerins GM, MacNicoll AD (1992) Inheritance of low grade brodifacoum resistance in the Norway rat. J Wildl Manage 56(4):809-816
3. Gill JE, Kerins GM, Langton SD et al. (1993) The developmentof a blood clotting response test for discriminating between difenacoum-resistant and susceptible Norway rats (Rattus norvegicus Berk.). Comp Biochem Physiol 104C(1):29-36
4. Gill JE, Kerins GM, Langton SD et al. (1994) Blood-clotting response test for bromadiolone resistance in Norway rats. J Wildl Manage 58(3):454-461
5. Greaves JH, Ayres PB (1967) Heritable resistance to warfarin in rats. Nature 215:877-878
6. Greaves JH, Cullen-Ayres PB (1988) Genetics of difenacoum resistance in the rat. In: Suttie JW (ed) Seventeenth Steenbocksymposium on current advances in vitamin K research. Elsevier, New York, pp 389-397
7. Harauchi T, Takano K, Matsura M et al. (1986) Liver and plasma levels of descarboxy prothrombin (PIVKA II) in vitamin K deficiency in rats. Japan J Pharmacol 40:491-499
8. Kerins GM, MacNicoll AD (1999) Comparison of the half-lives and regeneration rates of blood clotting factors II, VII and X in anticoagulant-resistant and susceptible Noway rats (Rattus norvegicus Berk.). Comp Biochem Physiol 122C(3):307-316
9. MacNicoll AD (1988) The role of altered vitamin K metabolism in anticoagulant resistance in rodents. In: Suttie JW (ed) Seventeenth Steenbock symposium on current advances in vitamin K research. Elsevier, New York, pp 407-417
10. Martin AD, Steed LC, Redfern R et al. (1979) Warfarin resistance genotype determination in the Norway rat (Rattus norvegicus). Lab Anim 13:209-214
11. Miller GJ (1992) Environmental influences on haemostasis and thrombosis: diet and smoking. Ann Epidemiol 2:387-391
12. Parmar G, Bratt H, Moore R et al. (1987) Evidence of a common binding site in vivo for the retention of anticoagulants in rat liver. Hum Toxicol 6:431-432
13. Redfern R, Gill JE (1978) The development anduse of a test to identify resistance to the anticoagulant difenacoum in the Norway rat (Rattus norvegicus). J Hyg 81:427-431
14. Stenflo J, Suttie JW (1977) Vitamin K-dependent formation of γ-carboxyglutamic acid. Annu Rev Biochem 46:157
15. Suttie JW, Jackson CM (1977) Prothrombin structure, activation, and biosynthesis. Physiol Rev 57:1
16. World Health Organisation (1975) Instructions for determining the susceptibility or resistance of rodents to anticoagulants. WHO Vector Control Series 75.595:1-7
17. Yacobi A, Levy G (1974) Pharmacokinetics of the warfarin enantiomers in rats. J Pharmacokin Biopharm 2:239-255
18. Zimmerman A, Matschiner JT (1974) Biochemical basis of hereditary resistance to warfarin in the rat. Biochem Pharmacol 23:1033-1040